Project details
- Project period
- 1 Oct 2024 - 31 Mar 2027
- Total cost
- €1 377 183,75
- Global Health EDCTP3 funding
- €1 371 783,75
- Call identifier
- HORIZON_HORIZON-JU-GH-EDCTP3-2024-Mpox
- Status
- In progress
- Project type
- Research and Innovation Actions (RIA)
- Disease area
- Emerging or re-emerging infectious diseases
- Intervention type
- VaccinesDiagnostics
- Overarching topic
- Health security
Consortium map
Coordinator
UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN
- Location
- DUBLIN, Ireland
- EU contribution
- €302 740,00
- Total cost
- €308 140,00
Beneficiaries
NATIONAL INSTITUTE FOR MEDICAL RESEARCH
- Location
- DAR ES SALAAM, Tanzania
- EU contribution
- €201 256,25
- Total cost
- €201 256,25
THE UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS
- Location
- ST ANDREWS, United Kingdom
- EU contribution
- €77 996,25
- Total cost
- €77 996,25
MAKERERE UNIVERSITY LUNG INSTITUTE
- Location
- KAMPALA, Uganda
- EU contribution
- €262 417,50
- Total cost
- €262 417,50
UGANDA NATIONAL HEALTH RESEARCH ORGANISATION
- Location
- Entebbe, Uganda
- EU contribution
- €311 425,00
- Total cost
- €311 425,00
UNIVERSITE CATHOLIQUE DE BUKAVU
- Location
- BUKAVU, Democratic Republic of the Congo
- EU contribution
- €215 948,75
- Total cost
- €215 948,75
Related projects
A platform for evaluating Lassa fever treatmentsThe INTEGRATE project is creating a clinical trial platform able to support efficacy studies on multiple Lassa fever therapeutics.
Enhancing genomic surveillance in the Great Lakes regionThe GREAT-LIFE project is building a genomics-based infrastructure to track existing and new infectious disease threats and...
Supporting mpox responses and research in eastern DRCThe MBOTE-SK project is embedding research within the response to the new clade Ib mpox outbreak in eastern DRC.